| A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially B | Phase I / Phase II | rekrutiert |
| A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Co | Phase II / Phase III | rekrutiert |
| A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies | Phase I / Phase II | rekrutiert |
| A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis | Phase III | rekrutiert |
| A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace) | — | rekrutiert |
| A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulce | Phase III | rekrutiert |
| A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic L | Phase III | rekrutiert |
| A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesit | Phase III | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Inv | Phase III | rekrutiert |
| A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Throm | Phase III | rekrutiert |
| A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 C | Phase II | rekrutiert |
| A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Sa | Phase III | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan | Phase III | rekrutiert |
| A Pivotal Study Evaluating Safety and Effectiveness of Adaptative Tip Catheter in Patients With | ohne Phasenangabe | rekrutiert |
| A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propi | Phase III | rekrutiert |
| A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With A | — | rekrutiert |
| A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart | Phase III | rekrutiert |
| A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disea | Phase I | rekrutiert |
| A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD | Phase III | rekrutiert |
| A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With | Phase IV | rekrutiert |
| A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NAS | Phase III | rekrutiert |
| A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis | Phase III | rekrutiert |
| A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Do | Phase III | rekrutiert |
| A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Ce | Phase III | rekrutiert |
| A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Mode | Phase II | rekrutiert |
| A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glu | — | rekrutiert |
| A Study of AZD0120 in Autoimmune Diseases | Phase I | rekrutiert |
| A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell | Phase I / Phase II | rekrutiert |
| A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With | Phase III | rekrutiert |
| A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First | Phase III | rekrutiert |
| A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Diseas | Phase II | rekrutiert |
| A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Adva | Phase II | rekrutiert |
| A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Al | Phase III | rekrutiert |
| A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone | Phase III | rekrutiert |
| A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin | — | rekrutiert |
| A Study of Brenipatide in Adult Participants With Major Depressive Disorder | Phase III | rekrutiert |
| A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adju | Phase III | rekrutiert |
| A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 D | Phase III | rekrutiert |
| A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelod | Phase II | rekrutiert |
| A Study of JNT-517 in Participants With Phenylketonuria (PKU) | Phase III | rekrutiert |
| A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy | Phase III | rekrutiert |
| A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tum | Phase I / Phase II | rekrutiert |
| A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants Wi | Phase III | rekrutiert |
| A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or L | Phase II | rekrutiert |
| A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With | Phase III | rekrutiert |
| A Study of Zasocitinib in Adults With Hidradenitis Suppurativa | Phase II | rekrutiert |
| A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Canc | Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associa | Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Int | Phase II / Phase III | rekrutiert |
| A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB | Phase III | rekrutiert |
| A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult an | Phase III | rekrutiert |
| A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa | Phase II | rekrutiert |
| A Study to Assess the Effects of Zigakibart on IgA Nephropathy. | Phase II | rekrutiert |
| A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spas | Phase I / Phase II | rekrutiert |
| A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Aga | Phase III | rekrutiert |
| A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus | Phase III | rekrutiert |
| A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Mo | Phase II | rekrutiert |
| A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms | Phase I | rekrutiert |
| A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept | Phase III | rekrutiert |
| A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adol | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplant | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Mo | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Re | Phase I / Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants Wi | Phase II | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzhe | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Ol | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Prima | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Ado | Phase III | rekrutiert |
| A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects | Phase II | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilim | Phase I / Phase II | rekrutiert |
| A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïv | Phase III | rekrutiert |
| A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Foc | Phase III | rekrutiert |
| A Study to Investigate Bowel Cleansing With PLENVU® Compared to Sodium Picosulfate in Participan | Phase III | rekrutiert |
| A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Part | Phase II | rekrutiert |
| A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Neph | Phase III | rekrutiert |
| A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomi | Phase III | rekrutiert |
| A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia | Phase III | rekrutiert |
| A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticos | Phase III | rekrutiert |
| A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rit | Phase III | rekrutiert |
| A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Ri | Phase III | rekrutiert |
| ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or | Phase I / Phase II | rekrutiert |
| ATLAS (AltaValve) Pivotal Trial | ohne Phasenangabe | rekrutiert |
| Abbott DBS Post-Market Study of Outcomes for Indications Over Time | — | rekrutiert |
| Abbott Vascular Medical Device Registry | — | rekrutiert |
| Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptom | Phase III | rekrutiert |
| Additional Chemotherapy for EGFRm Patients with the Continued Presence of Plasma CtDNA EGFRm At | Phase II | rekrutiert |
| Alcon Hydrus Stent Implantation - Long Term Follow up After 8 Years | — | rekrutiert |
| Alloplastic Total Temporomandibular Joint (TMJ) Replacement Registry | — | rekrutiert |
| An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients | — | rekrutiert |
| An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing | Phase I / Phase II | rekrutiert |
| Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer | ohne Phasenangabe | rekrutiert |
| Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIA | — | rekrutiert |
| Baroloop Multicenter Trial (Baroloop MCT) | ohne Phasenangabe | rekrutiert |
| Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | — | rekrutiert |
| Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa | Phase II | rekrutiert |
| CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma | Phase II | rekrutiert |
| CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry | — | rekrutiert |
| COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflib | Phase III | rekrutiert |
| COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina | ohne Phasenangabe | rekrutiert |
| Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and | Phase I | rekrutiert |
| Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ES | Phase II / Phase III | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| Comparing a Suture-based System for the Removal of Arterial and Veinous ECMO Cannulas to the Sta | ohne Phasenangabe | rekrutiert |
| Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Re | Phase IV | rekrutiert |
| Cyclosporine In Takotsubo Syndrome | Phase II | rekrutiert |
| DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to C | Phase III | rekrutiert |
| DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung | Phase II | rekrutiert |
| DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Pl | Phase II | rekrutiert |
| DEfeating PEnile CAncer-2 | ohne Phasenangabe | rekrutiert |
| Differential Effects of in Vivo and Virtual Exposure Therapy in Agoraphobia | ohne Phasenangabe | rekrutiert |
| Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Brea | Phase II | rekrutiert |
| Distribution of Lymph Node Metastases in Esophageal Carcinoma | — | rekrutiert |
| Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis | Phase I | rekrutiert |
| Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma | Phase II | rekrutiert |
| EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagl | Phase III | rekrutiert |
| EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in Peop | Phase III | rekrutiert |
| ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary | Phase III | rekrutiert |
| Effects of Autonomic Nervous System Modulation by Heart Rate Variability Biofeedback Training Wi | ohne Phasenangabe | rekrutiert |
| Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SG | Phase III | rekrutiert |
| Effects of Flow Magnitude on Cardiorespiratory Stability During Nasal High Flow Therapy in Prete | ohne Phasenangabe | rekrutiert |
| Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chron | Phase III | rekrutiert |
| Enhanced Valves Interventions and Safe AI Generated End Results | — | rekrutiert |
| Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With | Phase II | rekrutiert |
| Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disea | Phase II | rekrutiert |
| Fit to Fight Childhood Cancer | — | rekrutiert |
| Futibatinib in Combination With (Chemo)Immunotherapy in Colorectal Cancer and Other Solid Tumor | Phase II | rekrutiert |
| GISAR German Interdisciplinary Sarcoma Registry | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| GMMG Multiple Myeloma Registry | — | rekrutiert |
| German Dementia Registry | — | rekrutiert |
| German-funded Laparoscopic Approach to Cervical Cancer | ohne Phasenangabe | rekrutiert |
| Global Research Initiative for Patients Screening on MASH | — | rekrutiert |
| HOPE Against Cancer Recurrence in HCC | Phase IV | rekrutiert |
| IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL | Phase III | rekrutiert |
| INSIGHTFUL-FFR Clinical Trial | Phase IV | rekrutiert |
| Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multi | Phase III | rekrutiert |
| Identification of Liver Fibrosis Biomarkers | — | rekrutiert |
| Influence of Sarcopenia on the Course of the Diseases | — | rekrutiert |
| Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS) | ohne Phasenangabe | rekrutiert |
| Interdisciplinary + Intersectoral Telemedicine Evaluation, Coordination + Treatment in RhineMain | ohne Phasenangabe | rekrutiert |
| Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phen | Phase III | rekrutiert |
| International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-regist | — | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Pati | Phase I | rekrutiert |
| Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patie | Phase II | rekrutiert |
| Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH | Phase III | rekrutiert |
| LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Cal | Phase III | rekrutiert |
| LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MAS | Phase III | rekrutiert |
| LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus | ohne Phasenangabe | rekrutiert |
| Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdi | — | rekrutiert |
| Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRA | Phase III | rekrutiert |
| Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN | Phase III | rekrutiert |
| Lumbar Drainage of Intraventricular Hemorrhage | ohne Phasenangabe | rekrutiert |
| Lysosomal Acid Lipase (LAL) Deficiency Registry | — | rekrutiert |
| MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) | Phase III | rekrutiert |
| MICRO: a Registry Study in Patients With Microvascular Angina | — | rekrutiert |
| Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Tri | ohne Phasenangabe | rekrutiert |
| Mainz Intracoronary Database. The Coronary Slow-flow and Microvascular Diseases Registry | — | rekrutiert |
| Mainz Register of Patients With Sleep Disorders | — | rekrutiert |
| MiCLASP Post Market Clinical Follow-Up (PMCF) Study | — | rekrutiert |
| Mucopolysaccharidosis VII Disease Monitoring Program | — | rekrutiert |
| Mucous Fistula Refeeding Reduces the Time From Enterostomy Closure to Full Enteral Feeds ("MUC-F | ohne Phasenangabe | rekrutiert |
| Multi-professional Care Pathway and Network for the Promotion of Needs-oriented, Resident-orient | ohne Phasenangabe | rekrutiert |
| Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery Syste | — | rekrutiert |
| Multicenter Registry on Microvascular Dysfunction - Searching a New Ach Spasm Definition | — | rekrutiert |
| NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometr | — | rekrutiert |
| NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High- | — | rekrutiert |
| Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab | Phase II | rekrutiert |
| Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in A | Phase III | rekrutiert |
| Nivolumab in Children and Adults With Nasopharyngeal Carcinoma | Phase II | rekrutiert |
| Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis | — | rekrutiert |
| ORIGIN® vs. VANGUARD® PS Observational Study | — | rekrutiert |
| Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer | ohne Phasenangabe | rekrutiert |
| Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Ki | Phase I / Phase II | rekrutiert |
| PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches | — | rekrutiert |
| PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different | Phase II | rekrutiert |
| PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and | — | rekrutiert |
| Pan Tumor Rollover Study | Phase II | rekrutiert |
| Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally | Phase II | rekrutiert |
| Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma | Phase I / Phase II | rekrutiert |
| Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic | Phase II | rekrutiert |
| Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial | Phase II / Phase III | rekrutiert |
| Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negativ | Phase III | rekrutiert |
| Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in | Phase III | rekrutiert |
| Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mID | Phase II | rekrutiert |
| Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With New | Phase III | rekrutiert |
| Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for | Phase III | rekrutiert |
| Phase IIIb Study of Ribociclib + ET in Early Breast Cancer | Phase III | rekrutiert |
| Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients Wi | Phase II | rekrutiert |
| Pompe Disease Registry Protocol | — | rekrutiert |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - POR | Phase III | rekrutiert |
| Prediction of Blood Pressure Outcomes Following Renal Denervation (PREDICT-RDN) | ohne Phasenangabe | rekrutiert |
| Prospective Registry of Patients Undergoing Cardiac CT With NAEOTOM Alpha PCD-CT Before TAVI Pro | — | rekrutiert |
| Prospective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectio | Phase II | rekrutiert |
| Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer | Phase III | rekrutiert |
| RAMIE Versus MIE for Resectable Esophageal Cancer, a Randomized Controlled Trial (ROBOT-2 Trial) | ohne Phasenangabe | rekrutiert |
| Randomised Evaluation of Sodium Dialysate Levels on Vascular Events | Phase IV | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD- | Phase III | rekrutiert |
| Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Cou | Phase IV | rekrutiert |
| Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years Wi | — | rekrutiert |
| Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis | — | rekrutiert |
| Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Pro | — | rekrutiert |
| Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodul | — | rekrutiert |
| Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy | Phase II | rekrutiert |
| Reducing Cardiac-surgery Associated Acute Kidney Injury Occurence by Administering Angiotensin I | Phase III | rekrutiert |
| Register Schweres Asthma - German Asthma Net e.V. | — | rekrutiert |
| Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Ac | — | rekrutiert |
| Registry for Patients With X-Linked Hypophosphatemia | — | rekrutiert |
| Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry | — | rekrutiert |
| Respiratory Variation of Carotid Doppler Peak Velocity (CDPV) for Non-invasive Prediction of Flu | — | rekrutiert |
| Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearran | Phase III | rekrutiert |
| Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib | Phase III | rekrutiert |
| STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease | Phase III | rekrutiert |
| SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresect | Phase III | rekrutiert |
| Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR | Phase III | rekrutiert |
| Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone i | Phase III | rekrutiert |
| Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for P | Phase III | rekrutiert |
| Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Ther | Phase II / Phase III | rekrutiert |
| Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematol | Phase I / Phase II | rekrutiert |
| Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Inve | Phase II / Phase III | rekrutiert |
| Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participan | Phase III | rekrutiert |
| Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy | — | rekrutiert |
| Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants | Phase I | rekrutiert |
| Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced | Phase III | rekrutiert |
| Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With | Phase I / Phase II | rekrutiert |
| Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN | Phase III | rekrutiert |
| Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. | Phase III | rekrutiert |
| Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, | Phase II | rekrutiert |
| Study of INCA036978 in Participants With Myeloproliferative Neoplasms | Phase I | rekrutiert |
| Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH) | Phase II | rekrutiert |
| Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in | Phase II | rekrutiert |
| Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or | Phase II | rekrutiert |
| Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants W | Phase II | rekrutiert |
| Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis | Phase II | rekrutiert |
| Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspira | — | rekrutiert |
| Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With M | — | rekrutiert |
| Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma | Phase I / Phase II | rekrutiert |
| Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Im | Phase III | rekrutiert |
| Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-r | Phase IV | rekrutiert |
| Tendyne European Experience Registry | — | rekrutiert |
| The "Global Paradise System" Registry | — | rekrutiert |
| The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in I | Phase III | rekrutiert |
| The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis | Phase III | rekrutiert |